home / open_comments

documents

Federal regulatory documents currently open for public comment.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

134 rows where document_type = "Other" sorted by comment_end_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: docket_id, subtype, posted_date, posted_month, comment_start_date, comment_end_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

agency_id 8

  • FDA 110
  • EPA 7
  • NARA 6
  • ITA 5
  • BOEM 3
  • CFTC 1
  • FAA 1
  • IRS 1

document_type 1

  • Other · 134 ✖
id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date ▲ last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-P-0749-0001 FDA FDA-2026-P-0749 Citizen Petition from Apotex Inc. Other Citizen Petition 2026-01-26 2026 1 2026-01-26 2026-07-23 2026-01-27 01:08:18   1 0 09000064b9182c73
FDA-2026-D-1255-0002 FDA FDA-2026-D-1255 Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing; Draft Guidance for Industry Other Guidance 2026-04-15 2026 4 2026-04-15 2026-07-15 2026-04-16 09:00:16   1 0 09000064b9282a2a
IRS-2026-0134-0001 IRS IRS-2026-0134 Rev Proc 2026-13 Other   2026-02-17 2026 2 2026-02-17 2026-05-23 2026-02-18 00:07:14   1 0 09000064b91b5dc2
FDA-2025-D-2837-0002 FDA FDA-2025-D-2837 Questions and Answers About Requirements for Additional Traceability Records for Certain Foods: Guidance for Industry - Draft Guidance Other Guidance 2026-02-20 2026 2 2026-02-20 2026-05-22 2026-02-20 20:47:16   1 0 09000064b91c9d9a
FDA-2026-N-1304-0001 FDA FDA-2026-N-1304 Agenda for the U.S. Food and Drug Administration (FDA) Virtual Public Meeting Food Allergen Thresholds and Their Potential Applications 2-18-2026 Other Agenda 2026-02-18 2026 2 2026-02-18 2026-05-20 2026-04-10 09:00:23   1 0 09000064b91b5eeb
FDA-2025-D-6131-0002 FDA FDA-2025-D-6131 General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance Other Guidance 2026-03-19 2026 3 2026-03-19 2026-05-19 2026-04-15 09:00:24   1 0 09000064b9223609
FDA-2011-D-0611-0094 FDA FDA-2011-D-0611 New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 4) Guidance for Industry - Draft Guidance Other Guidance 2026-03-10 2026 3 2026-03-10 2026-05-12 2026-03-14 09:00:14   1 0 09000064b92071bb
FDA-2026-D-1817-0002 FDA FDA-2026-D-1817 Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications—Considerations Related to Youth Risk - Draft Guidance for Industry Other Guidance 2026-03-11 2026 3 2026-03-11 2026-05-12 2026-04-14 09:00:19   1 0 09000064b920c96d
FAA-2024-2531-0513 FAA FAA-2024-2531 Notice of Request for Comment on the Part 141 Modernization Industry (Draft) Other Request 2026-04-08 2026 4 2026-04-08 2026-05-12 2026-04-12 09:00:15   1 0 09000064b925e814
FDA-2025-D-1504-0002 FDA FDA-2025-D-1504 Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry Other Guidance 2026-03-09 2026 3 2026-03-09 2026-05-09 2026-04-10 09:00:26   1 0 09000064b9200f6d
EPA-R05-OW-2025-2730-0001 EPA EPA-R05-OW-2025-2730 CEFactSheetJHC_2026 Other   2026-04-01 2026 4 2026-04-01 2026-05-05 2026-04-16 09:00:14   1 0 09000064b924a305
FDA-2024-D-4388-0002 FDA FDA-2024-D-4388 New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers Guidance for Industry - Draft Guidance Other Guidance 2026-03-04 2026 3 2026-03-04 2026-05-05 2026-03-09 09:00:19   1 0 09000064b91ef6ec
CFTC-2026-0562-0001 CFTC   Testing a basic pdf Other   2026-04-08 2026 4 2026-04-08 2026-05-01 2026-04-14 18:38:10   1 0 09000064b9261422
ITA-2025-0040-0002 ITA ITA-2025-0040 Submission 2. Aluminum Extruders Council Other   2026-04-15 2026 4 2026-04-15 2026-04-30 2026-04-15 17:37:37   1 0 09000064b927c519
ITA-2025-0040-0005 ITA ITA-2025-0040 Submission 4. RealTruck Enterprise Inc. Other   2026-04-15 2026 4 2026-04-15 2026-04-30 2026-04-15 17:37:57   1 0 09000064b9282a45
ITA-2025-0040-0003 ITA ITA-2025-0040 Submission 3. Viking Products 1 of 2 Other   2026-04-15 2026 4 2026-04-15 2026-04-30 2026-04-15 17:37:44   1 0 09000064b9282a3f
ITA-2025-0040-0001 ITA ITA-2025-0040 Submission 1. EMPI INC Other   2026-04-15 2026 4 2026-04-15 2026-04-30 2026-04-15 17:37:30   1 0 09000064b9268443
EPA-R09-OAR-2024-0028-0003 EPA EPA-R09-OAR-2024-0028 Draft Permit - NTEC Energy Generation Plant - APP# 2024-004-SM Other   2026-03-19 2026 3 2026-03-19 2026-04-30 2026-03-29 09:00:14   1 0 09000064b9222e7a
ITA-2025-0040-0004 ITA ITA-2025-0040 Submission 3. Viking Products 2 of 2 Other   2026-04-15 2026 4 2026-04-15 2026-04-30 2026-04-15 17:37:50   1 0 09000064b9282a3a
FDA-2007-D-0369-2526 FDA FDA-2007-D-0369 PSG_220073 - Draft Guidance on Apixaban Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-03-20 09:00:19   1 0 09000064b91e01f3
FDA-2007-D-0369-2525 FDA FDA-2007-D-0369 PSG_219104 - Draft Guidance on Letermovir Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:52:13   1 0 09000064b91e01dd
FDA-2007-D-0369-2524 FDA FDA-2007-D-0369 PSG_219097 - Draft Guidance on Imatinib Mesylate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:51:42   1 0 09000064b91e01db
FDA-2007-D-0369-2521 FDA FDA-2007-D-0369 PSG_218550 - Draft Guidance on Entrectinib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:50:35   1 0 09000064b91e01d5
FDA-2007-D-0369-2519 FDA FDA-2007-D-0369 PSG_218316 - Draft Guidance on Semaglutide Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:49:49   1 0 09000064b91e01d1
FDA-2007-D-0369-2437 FDA FDA-2007-D-0369 PSG_019758 - Draft Guidance on Clozapine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:20:28   1 0 09000064b91df4ce
FDA-2007-D-0369-2433 FDA FDA-2007-D-0369 PSG_018731 - Draft Guidance on Buspirone Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:19:11   1 0 09000064b91df467
FDA-2007-D-0369-2445 FDA FDA-2007-D-0369 PSG_020310 - Draft Guidance on Ketoconazole Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:22:59   1 0 09000064b91df4ee
FDA-2007-D-0369-2452 FDA FDA-2007-D-0369 PSG_020870 - Draft Guidance on Estradiol; Norethindrone Acetate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:25:03   1 0 09000064b91e0106
FDA-2007-D-0369-2463 FDA FDA-2007-D-0369 PSG_021590 - Draft Guidance on Clozapine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:30:34   1 0 09000064b91e0127
FDA-2007-D-0369-2471 FDA FDA-2007-D-0369 PSG_022549 - Draft Guidance on Loxapine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:33:45   1 0 09000064b91e0138
FDA-2007-D-0369-2499 FDA FDA-2007-D-0369 PSG_214187 - Draft Guidance on Sofosbuvir; Velpatasvir Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:43:04   1 0 09000064b91e018e
FDA-2007-D-0369-2474 FDA FDA-2007-D-0369 PSG_202155 - Draft Guidance on Apixaban Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:34:51   1 0 09000064b91e013e
FDA-2007-D-0369-2504 FDA FDA-2007-D-0369 PSG_215110 - Draft Guidance on Glecaprevir; Pibrentasvir Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:44:51   1 0 09000064b91e0198
FDA-2007-D-0369-2502 FDA FDA-2007-D-0369 PSG_214826 - Draft Guidance on Lorazepam Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:44:20   1 0 09000064b91e0194
FDA-2007-D-0369-2487 FDA FDA-2007-D-0369 PSG_210136 - Draft Guidance on Buprenorphine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:39:03   1 0 09000064b91e016c
FDA-2007-D-0369-2478 FDA FDA-2007-D-0369 PSG_205395 - Draft Guidance on Cobicistat; Darunavir Ethanolate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:36:14   1 0 09000064b91e0150
FDA-2007-D-0369-2518 FDA FDA-2007-D-0369 PSG_217514 - Draft Guidance on Dabrafenib Mesylate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:49:32   1 0 09000064b91e01cf
FDA-2007-D-0369-2470 FDA FDA-2007-D-0369 PSG_022395 - Draft Guidance on Capsaicin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:33:25   1 0 09000064b91e0135
FDA-2007-D-0369-2468 FDA FDA-2007-D-0369 PSG_022198 - Draft Guidance on Granisetron Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:32:47   1 0 09000064b91e0131
FDA-2007-D-0369-2483 FDA FDA-2007-D-0369 PSG_208036 - Draft Guidance on Barium Sulfate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:37:51   1 0 09000064b91e015a
FDA-2007-D-0369-2465 FDA FDA-2007-D-0369 PSG_021986 - Draft Guidance on Dasatinib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:31:13   1 0 09000064b91e012b
FDA-2007-D-0369-2430 FDA FDA-2007-D-0369 PSG_017628 - Draft Guidance on Tolmetin Sodium Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:18:11   1 0 09000064b91df461
FDA-2007-D-0369-2450 FDA FDA-2007-D-0369 PSG_020612 - Draft Guidance on Lidocaine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:24:27   1 0 09000064b91df4f8
FDA-2007-D-0369-2451 FDA FDA-2007-D-0369 PSG_020831 - Draft Guidance on Formoterol Fumarate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:24:44   1 0 09000064b91e0104
FDA-2007-D-0369-2455 FDA FDA-2007-D-0369 PSG_021258 - Draft Guidance on Estradiol; Levonorgestrel Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:25:50   1 0 09000064b91e010c
FDA-2007-D-0369-2436 FDA FDA-2007-D-0369 PSG_019081 - Draft Guidance on Estradiol Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:20:10   1 0 09000064b91df4cc
FDA-2007-D-0369-2505 FDA FDA-2007-D-0369 PSG_215352 - Draft Guidance on Phenylephrine Hydrochloride; Tropicamide Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-03-27 09:00:14   1 0 09000064b91e019a
FDA-2007-D-0369-2456 FDA FDA-2007-D-0369 PSG_021306 - Draft Guidance on Buprenorphine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:26:18   1 0 09000064b91e0119
FDA-2007-D-0369-2458 FDA FDA-2007-D-0369 PSG_021351 - Draft Guidance on Oxybutynin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:27:00   1 0 09000064b91e011d
FDA-2007-D-0369-2510 FDA FDA-2007-D-0369 PSG_216318 - Draft Guidance on Testosterone Cypionate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:46:43   1 0 09000064b91e01b1
FDA-2007-D-0369-2513 FDA FDA-2007-D-0369 PSG_216675 - Draft Guidance on Perfluorohexyloctane Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:47:39   1 0 09000064b91e01b8
FDA-2007-D-0369-2462 FDA FDA-2007-D-0369 PSG_021588 - Draft Guidance on Imatinib Mesylate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:29:47   1 0 09000064b91e0125
FDA-2007-D-0369-2449 FDA FDA-2007-D-0369 PSG_020538 - Draft Guidance on Estradiol Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:24:10   1 0 09000064b91df4f6
FDA-2007-D-0369-2431 FDA FDA-2007-D-0369 PSG_017874 - Draft Guidance on Scopolamine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:18:30   1 0 09000064b91df463
FDA-2007-D-0369-2434 FDA FDA-2007-D-0369 PSG_018859 - Draft Guidance on Ribavirin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:19:33   1 0 09000064b91df4c8
FDA-2007-D-0369-2496 FDA FDA-2007-D-0369 PSG_213004 - Draft Guidance on Amoxicillin; Omeprazole Magnesium; Rifabutin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:41:55   1 0 09000064b91e0188
FDA-2007-D-0369-2477 FDA FDA-2007-D-0369 PSG_204017 - Draft Guidance on Ethinyl Estradiol; Levonorgestrel Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:35:51   1 0 09000064b91e014e
FDA-2007-D-0369-2491 FDA FDA-2007-D-0369 PSG_212268 - Draft Guidance on Asenapine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:40:16   1 0 09000064b91e017e
FDA-2007-D-0369-2501 FDA FDA-2007-D-0369 PSG_214522 - Draft Guidance on Tadalafil Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:44:01   1 0 09000064b91e0192
FDA-2007-D-0369-2485 FDA FDA-2007-D-0369 PSG_208171 - Draft Guidance on Ferric Derisomaltose Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:38:28   1 0 09000064b91e015e
FDA-2007-D-0369-2472 FDA FDA-2007-D-0369 PSG_050440 - Draft Guidance on Cephalexin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:34:04   1 0 09000064b91e013a
FDA-2007-D-0369-2498 FDA FDA-2007-D-0369 PSG_213953 - Draft Guidance on Testosterone Undecanoate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:42:31   1 0 09000064b91e018c
FDA-2007-D-0369-2493 FDA FDA-2007-D-0369 PSG_212306 - Draft Guidance on Selinexor Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:40:55   1 0 09000064b91e0182
FDA-2007-D-0369-2503 FDA FDA-2007-D-0369 PSG_215039 - Draft Guidance on Alpelisib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:44:36   1 0 09000064b91e0196
FDA-2007-D-0369-2492 FDA FDA-2007-D-0369 PSG_212304 - Draft Guidance on Donepezil Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:40:33   1 0 09000064b91e0180
FDA-2007-D-0369-2515 FDA FDA-2007-D-0369 PSG_217202 - Draft Guidance on Landiolol Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:48:39   1 0 09000064b91e01bc
FDA-2007-D-0369-2517 FDA FDA-2007-D-0369 PSG_217370 - Draft Guidance on Acoltremon Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:49:14   1 0 09000064b91e01cd
FDA-2007-D-0369-2514 FDA FDA-2007-D-0369 PSG_216962 - Draft Guidance on Foscarbidopa; Foslevodopa Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:48:20   1 0 09000064b91e01ba
FDA-2007-D-0369-2523 FDA FDA-2007-D-0369 PSG_219016 - Draft Guidance on Rilpivirine Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:51:25   1 0 09000064b91e01d9
FDA-2007-D-0369-2439 FDA FDA-2007-D-0369 PSG_019927 - Draft Guidance on Ketoconazole Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:21:03   1 0 09000064b91df4d2
FDA-2007-D-0369-2453 FDA FDA-2007-D-0369 PSG_021180 - Draft Guidance on Ethinyl Estradiol; Norelgestromin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:25:18   1 0 09000064b91e0108
FDA-2007-D-0369-2435 FDA FDA-2007-D-0369 PSG_018891 - Draft Guidance on Clonidine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:19:51   1 0 09000064b91df4ca
FDA-2007-D-0369-2441 FDA FDA-2007-D-0369 PSG_020076 - Draft Guidance on Nicotine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:21:38   1 0 09000064b91df4d6
FDA-2007-D-0369-2429 FDA FDA-2007-D-0369 PSG_012283 - Draft Guidance on Chlorthalidone Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:17:46   1 0 09000064b91df45f
FDA-2007-D-0369-2480 FDA FDA-2007-D-0369 PSG_206968 - Draft Guidance on Acetaminophen Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:36:59   1 0 09000064b91e0154
FDA-2007-D-0369-2482 FDA FDA-2007-D-0369 PSG_207962 - Draft Guidance on Lidocaine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:37:34   1 0 09000064b91e0158
FDA-2007-D-0369-2476 FDA FDA-2007-D-0369 PSG_203479 - Draft Guidance on Clozapine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:35:30   1 0 09000064b91e014c
FDA-2007-D-0369-2495 FDA FDA-2007-D-0369 PSG_212526 - Draft Guidance on Alpelisib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:41:39   1 0 09000064b91e0186
FDA-2007-D-0369-2484 FDA FDA-2007-D-0369 PSG_208143 - Draft Guidance on Barium Sulfate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:38:13   1 0 09000064b91e015c
FDA-2007-D-0369-2494 FDA FDA-2007-D-0369 PSG_212516 - Draft Guidance on Duloxetine Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:41:20   1 0 09000064b91e0184
FDA-2007-D-0369-2500 FDA FDA-2007-D-0369 PSG_214410 - Draft Guidance on Baloxavir Marboxil Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:43:31   1 0 09000064b91e0190
FDA-2007-D-0369-2454 FDA FDA-2007-D-0369 PSG_021234 - Draft Guidance on Diclofenac Epolamine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:25:35   1 0 09000064b91e010a
FDA-2007-D-0369-2448 FDA FDA-2007-D-0369 PSG_020489 - Draft Guidance on Testosterone Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:23:57   1 0 09000064b91df4f4
FDA-2007-D-0369-2446 FDA FDA-2007-D-0369 PSG_020357 - Draft Guidance on Metformin Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:23:14   1 0 09000064b91df4f0
FDA-2007-D-0369-2460 FDA FDA-2007-D-0369 PSG_021447 - Draft Guidance on Tizanidine Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:27:59   1 0 09000064b91e0121
FDA-2007-D-0369-2443 FDA FDA-2007-D-0369 PSG_020145 - Draft Guidance on Nitroglycerin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:22:16   1 0 09000064b91df4da
FDA-2007-D-0369-2507 FDA FDA-2007-D-0369 PSG_215429 - Draft Guidance on Venlafaxine Besylate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:45:49   1 0 09000064b91e01ab
FDA-2007-D-0369-2516 FDA FDA-2007-D-0369 PSG_217225 - Draft Guidance on Avacincaptad Pegol Sodium Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:48:56   1 0 09000064b91e01cb
FDA-2007-D-0369-2509 FDA FDA-2007-D-0369 PSG_215602 - Draft Guidance on Baclofen Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:46:21   1 0 09000064b91e01af
FDA-2007-D-0369-2522 FDA FDA-2007-D-0369 PSG_218585 - Draft Guidance on Aceclidine Hydrochloride Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:51:02   1 0 09000064b91e01d7
FDA-2007-D-0369-2506 FDA FDA-2007-D-0369 PSG_215401 - Draft Guidance on Dextroamphetamine Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:45:23   1 0 09000064b91e01a9
FDA-2007-D-0369-2486 FDA FDA-2007-D-0369 PSG_209310 - Draft Guidance on Mometasone Furoate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:38:46   1 0 09000064b91e016a
FDA-2007-D-0369-2488 FDA FDA-2007-D-0369 PSG_210868 - Draft Guidance on Lorlatinib Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:39:21   1 0 09000064b91e016e
FDA-2007-D-0369-2473 FDA FDA-2007-D-0369 PSG_085635 - Draft Guidance on Testosterone Cypionate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:34:27   1 0 09000064b91e013c
FDA-2007-D-0369-2469 FDA FDA-2007-D-0369 PSG_022264 - Draft Guidance on Paliperidone Palmitate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:33:09   1 0 09000064b91e0133
FDA-2007-D-0369-2479 FDA FDA-2007-D-0369 PSG_206089 - Draft Guidance on Testosterone Undecanoate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:36:31   1 0 09000064b91e0152
FDA-2007-D-0369-2489 FDA FDA-2007-D-0369 PSG_211733 - Draft Guidance on Acetaminophen; Ibuprofen Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:39:39   1 0 09000064b91e0170
FDA-2007-D-0369-2481 FDA FDA-2007-D-0369 PSG_207620 - Draft Guidance on Sacubitril; Valsartan Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:37:17   1 0 09000064b91e0156
FDA-2007-D-0369-2490 FDA FDA-2007-D-0369 PSG_211843 - Draft Guidance on Tiopronin Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:39:55   1 0 09000064b91e0172
FDA-2007-D-0369-2497 FDA FDA-2007-D-0369 PSG_213224 - Draft Guidance on Octreotide acetate Other Guidance 2026-02-27 2026 2 2026-02-27 2026-04-29 2026-02-27 19:42:17   1 0 09000064b91e018a

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
            id TEXT PRIMARY KEY,
            agency_id TEXT,
            docket_id TEXT,
            title TEXT,
            document_type TEXT,
            subtype TEXT,
            posted_date TEXT,
            posted_year INTEGER,
            posted_month INTEGER,
            comment_start_date TEXT,
            comment_end_date TEXT,
            last_modified TEXT,
            fr_doc_num TEXT,
            open_for_comment INTEGER,
            withdrawn INTEGER,
            object_id TEXT
        );
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date);
CREATE INDEX idx_docs_withdrawn ON documents(withdrawn);
Powered by Datasette · Queries took 15.801ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API